Xwell (XWEL) Preferred Stock Liabilities (2025)

Xwell (XWEL) posted Preferred Stock Liabilities of $224000.0 for Q4 2025, down 32.33% sequentially from $331000.0 in Q3 2025.

Xwell (XWEL) Preferred Stock Liabilities (2025) Analysis & Trends

Xwell has reported Preferred Stock Liabilities for 1 years, with the latest figure at $224000.0 in Q4 2025.

Quarterly Preferred Stock Liabilities changed N/A year-over-year to $224000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $224000.0 (changed N/A YoY) and the FY2025 annual result came in at $224000.0, changed N/A from the prior year.
Preferred Stock Liabilities declined to $224000.0 in Q4 2025 per XWEL's latest filing, from $331000.0 in the prior quarter.
Over five years, Preferred Stock Liabilities peaked at $567000.0 in Q1 2025 and troughed at $224000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	-
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	-
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	-
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	-
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	-
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	-
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	-
10	Xwell	7.47 Mn	-9.34 Mn	2.35 Mn	-

Download Data